The Centers for Disease Control and Prevention (CDC) on Saturday released a new guideline stating that people with internal health conditions can get the coronavirus vaccine.
Guidance Explains that “Adults of any age with certain underlying medical conditions have an increased risk of developing a serious illness from the virus that causes COVID-19. ”
Thus, the CDC added that Vaccines approved by the Food and Drug Administration (FDA)People with underlying medical conditions may be administered if they have not had a severe allergic reaction to any of the components of the vaccine. ”
The CDC explained that people with weakened immune systems due to other illnesses or medications can also get the Covid-19 vaccine, but they should be aware that there are limited safety data available on the effectiveness of vaccines on these individuals.
Additionally, when people living with HIV were included in clinical trials, safety data were also not available for this group.
The CDC also said in its Saturday guidance that individuals with autoimmune status can be vaccinated, although no data are currently available for vaccine safety in this demographic issue.
Those who have experienced Guillain-Barr સિ syndrome – a condition in which the body begins to attack parts of its own nervous system – may also receive a dose of the vaccine. The guide added that after vaccination during clinical trials, there were no instances of the syndrome.
People who have previously experienced Bell’s paralysis – a condition that causes muscle weakness on one side of the face – may also be vaccinated. During the clinical trial some participants developed Bell’s paralysis after vaccination, but it was not seen at a higher rate than expected in the general population.
Despite the beginning of the distribution of Pfizer / Bioentech and Moderna vaccines, the CDC recommends that those who are vaccinated should continue to adhere to current coronavirus health and safety protocols, such as wearing masks, avoiding social distance and congestion.
According to the CDC, About 2 million people By Saturday they have received the first dose of coronavirus vaccine. Both the vaccine developed by Pfizer and Bioentech and the Moderna vaccine require two doses in addition to a few weeks.
Final trial data on both vaccines showed that they had a 95 percent efficacy rate in preventing COVID-19, although The Moderna vaccine has an 86 percent effectiveness rate for people over the age of 65.
Preference is given to health care workers in the initial distribution of vaccines, and the CDC’s Advisory Committee on the Immune System (ACIP) Voted last week Advise the CDC to include emergency responders and certain front-line workers, including emergency responders and teachers, in the next phase of coronavirus vaccination.
.
